BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04938817-completion@plaintrial.com
DTSTAMP:20261027T191212Z
DTSTART;VALUE=DATE:20291210
SUMMARY:Safety and Efficacy Study of Investigational Agents as Monotherapy 
 or in Combination With Pembrolizumab (MK-3475) for the Treatment of Extens
 ive-Stage Small Cell Lung Cancer (ES-SCLC) in Need of Second-Line Therapy 
 (MK-3475-B98/KEYNOTE-B98) — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT04938817
URL:https://plaintrial.com/trial/NCT04938817
END:VEVENT
END:VCALENDAR